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Editorial 527 Primed for lethal battle: A step forward to enhance the efficacy and efficiency
of stem cell transplantation therapy
Molly E. Ogle, BS, Shan Ping Yu, MD, PhD, and Ling Wei, MD, Atlanta, Ga
Congenital Heart
Disease (CHD)
528 The Norwood procedure using a right ventricle–pulmonary artery conduit:
Comparison of the right-sided versus left-sided conduit position
David J. Barron, FRCS, Andre Brooks, MD, John Stickley, BSc, Steven M. Woolley, FRCS,
Oliver Stu¨mper, PhD, Timothy J. Jones, FRCS, and William J. Brawn, FRCS, Birmingham,
United Kingdom
Reconstruction of the central pulmonary arteries during the stage II Norwood procedure can be
difficult with a right ventricle–pulmonary artery (RV–PA) conduit. We describe an RV–PA conduit
routed to the right of the neoaorta in 125 patients that improves access to the pulmonary arteries and
reduces bypass times during the stage II procedure. The technique was associated with 88% early
survival and carried a survival benefit at 6 months over that seen with the classical Norwood
procedure, which was not seen with the left-sided conduits. This might be related to the longer length
(and resistance) of the right conduit compared with the left conduit.
538 Association of neonatal hypoxia with lasting changes in left ventricular gene
expression: An animal model
Danny Del Duca, MD, Guoruey Wong, BASc, Phan Trieu, BSc, Demetra Rodaros, BSc,
Athanasios Kouremenos, BSc, Artavazd Tadevosyan, MSc, George Vaniotis, BSc,
Louis R. Villeneuve, MSc, Christo I. Tchervenkov, MD, Stanley Nattel, MD, Bruce G. Allen, PhD,
Terence E. He´bert, PhD, and Charles V. Rohlicek, MD, PhD, Montre´al, Que´bec, Canada
Gene expression profiling was performed in left ventricular tissue from 10- and 90-day-old rats after
exposure to hypoxia for the first 10 days of life. Significant changes in expressions of a wide array of
genes, including those associated with vascular remodeling, energy homeostasis, and apoptosis,
persisted into adult life.
547 Coarctation repair in neonates and young infants: Is small size or lowweight still
a risk factor?
Phillip T. Burch, MD, Collin G. Cowley, MD, Richard Holubkov, PhD, Donald Null, MD,
Linda M. Lambert, MSN, FNP, Peter C. Kouretas, MD, PhD, and John A. Hawkins, MD,
Salt Lake City, Utah
Actuarial freedom from recurrent obstruction after simple coarctation repair in 167 infants younger
than 3 months was 89% at 5 years. This was similar for infants weighing less than 2.5 kg and those
weighing 2.5 kg or greater. In the current era, low birth weight does not affect the incidence of
reintervention after coarctation repair, and the timing of the operation should be based on clinical
status.














TX553 Pulmonary valve replacement in repaired tetralogy of Fallot: Determinants
of early postoperative adverse outcomes
Laura Dos, MD, Alexander Dadashev, MD, David Tanous, MBBS,
Ignacio J. Ferreira-Gonza´lez, MD, Kim Haberer, Samuel C. Siu, MD, Glen S. Van Arsdell, MD,
Erwin N. Oechslin, MD, William G. Williams, MD, and Candice K. Silversides, MD, Toronto,
Ontario, Canada, and Barcelona, Spain
Mortality after pulmonary valve replacement in patients with repaired tetralogy of Fallot is low, and
most patients have an uncomplicated postoperative course. When postoperative complications occur,
they are associated with prolonged hospitalization. Older patients (age .45 years), those with
multiple previous sternotomies, and those undergoing urgent operations are at higher risk.
560 Aminoterminal brain-type natriuretic peptide levels correlate with heart failure
in patients with bidirectional Glenn anastomosis and with morbidity after the
Fontan operation
Evelyn Lechner, MD, Elisabeth M. Schreier-Lechner, MD, Anna Hofer, MD, Roland Gitter, MD,
Rudolf Mair, MD, Ariane Biebl, MD, and Gerald Tulzer, MD, PhD, Linz, Austria
In 78 patients with a bidirectional Glenn (BDG) anastomosis, aminoterminal pro–brain natriuretic
peptide (NT–pro-BNP) plasma levels and severity of congestive heart failure (CHF) were assessed.
NT–pro-BNP levels of patients after BDG anastomosis without CHF were not increased, and plasma
NT–pro-BNP concentrations correlated with the severity of CHF and morbidity after the Fontan
operation.
565 Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical
outcome of conotruncal heart defects
Guido Michielon, MD, Bruno Marino, MD, Gianluca Oricchio, MD, Maria Cristina Digilio, MD,
Fiore Iorio, MD, Sergio Filippelli, MD, Silvia Placidi, MD, and Roberto M. Di Donato, MD,
Rome, Italy
This retrospective study reviews the outcome of 787 patients who underwent repair of CTHDs
between 1992 and 2007. Proven genetic syndrome was diagnosed in 211 patients (26.8%).
Fifteen-year survival was 84.3%6 2.3% in nonsyndromic patients and 73.2%6 4.2% in syndromic
patients (P , .001). Del22q11 and trisomy 21 did not represent a risk factor for mortality.
571 The practical clinical value of three-dimensional models of complex congenitally
malformed hearts
Euge´nie Riesenkampff, MD, Urte Rietdorf, MSc, Ivo Wolf, PhD, Bernhard Schnackenburg, PhD,
Peter Ewert, MD, Michael Huebler, MD, Vladimir Alexi-Meskishvili, MD, Robert H. Anderson, MD,
Nicole Engel, MD, Hans-Peter Meinzer, PhD, Roland Hetzer, MD, Felix Berger, MD, and
Titus Kuehne, MD, Berlin, Heidelberg, and Hamburg, Germany; London, United Kingdom
In complex congenital heart diseases, current standard imaging techniques do not always elucidate all
required anatomic information in a comprehensive manner for planning the optimum surgical
treatment strategy. We report our initial clinical experiences with the use of realistic 3-dimensional
heart models to facilitate preoperative planning.
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581 Effect of sympathectomy level on the incidence of compensatory hyperhidrosis
after sympathectomy for palmar hyperhidrosis
Daniel L. Miller, MD, Ayesha S. Bryant, MSPH, MD, Seth D. Force, MD, and
Joseph I. Miller, Jr, MD, Atlanta, Ga
Compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis can be reduced
significantly by dividing the sympathetic chain at a single level (T2). Older patients and patients with
increased body mass index should be warned about the increased risk of compensatory hyperhidrosis
after sympathtectomy and should possibly undergo a temporary sympathetic block to assess the
potential for compensatory hyperhidrosis.
586 Structural and morphologic evaluation of a novel detergent–enzymatic
tissue-engineered tracheal tubular matrix
Philipp Jungebluth, Tetsuhiko Go, MD, Adelaide Asnaghi, Silvia Bellini, PhD, Jaume Martorell, MD,
Chiara Calore, PhD, Luca Urbani, Helmut Ostertag, MD, PhD, Sara Mantero, PhD,
Maria Teresa Conconi, PhD, and Paolo Macchiarini, MD, PhD, Barcelona, Spain; Milano and
Padua, Italy; and Hannover, Germany
We bioengineered a 6-cm-long tracheal tubular matrix in vitro. On implantation as a heterotopic
allograft/xenograft in animals, this matrix maintained its viability and mechanical and morphologic
characteristics over a 30-day period without immunosuppression.
594 Clinical characteristics, biologic behavior, and survival after esophagectomy are
similar for adenocarcinoma of the gastroesophageal junction and the distal
esophagus
Jessica M. Leers, MD, Steven R. DeMeester, MD, Nadia Chan, MS, Shahin Ayazi, MD,
Arzu Oezcelik, MD, Emmanuele Abate, MD, Farzaneh Banki, MD, John C. Lipham, MD,
Jeffrey A. Hagen, MD, and Tom R. DeMeester, MD, Los Angeles, Calif
It has been suggested that adenocarcinoma of the gastroesophageal junction differs from
adenocarcinoma of the distal esophagus. We retrospectively reviewed our experience with
esophagectomy for adenocarcinoma at these locations and show that there is a similar prevalence
and pattern of lymph node metastases, type of recurrence, and survival. Efforts to differentiate
between adenocarcinoma of the distal esophagus or gastroesophageal junction are unnecessary, and
both are effectively treated with esophagectomy.
603 Silver nitrate through flexible bronchoscope in the treatment of bronchopleural
fistulae
Grigoris Stratakos, MD, Lina Zuccatosta, MD, Ilias Porfyridis, MD, Michele Sediari, MD,
Charalambos Zisis, MD, FETCS, Vasso Mariatou, MD, Eleftherios Kostopoulos, MD,
Argini Psevdi, MD, Spyros Zakynthinos, MD, and Stefano Gasparini, MD, Athens, Greece, and
Ancona, Italy
Small bronchopleural fistulae (#5 mm) of proximal airways were managed with silver nitrate
application via flexible videobronchoscopy. The success rate was 82%, whereas treatment failure was
noted in 2 cases treated only 15 days after surgical resection. This technique has promising results in
fistulae occurring at least 1 month after surgery.
(continued on page 18A)














TX608 The sentinel node concept in adenocarcinomas of the distal esophagus and
gastroesophageal junction
Brechtje A. Grotenhuis, MD, Bas P. L. Wijnhoven, MD, PhD, Ronald van Marion,
Herman van Dekken, MD, PhD, Wim C. Hop, PhD, Hugo W. Tilanus, MD, PhD,
J. Jan B. van Lanschot, MD, PhD, and Casper H. J. van Eijck, MD, PhD, Rotterdam,
The Netherlands
In this study we investigated whether the application of the sentinel node procedure is feasible in
esophageal adenocarcinoma and whether it can tailor surgical treatment of the individual patient.
613 A novel method for determining adjacent lung segments with infrared
thoracoscopy
Noriyuki Misaki, MD, Sung Soo Chang, MD, Masashi Gotoh, MD, PhD,
Yasumichi Yamamoto, MD, PhD, Katashi Satoh, MD, PhD, and Hiroyasu Yokomise, MD, PhD,
Kagawa, Japan
This experimental animal study attempted to visualize the transition zone between a target pulmonary
segment and another segment by using infrared thoracoscopy with intravenous injection of
indocyanine green based on blood flow without lung inflation. We proved that the color transition
zone was the intersegmental line based on pathologic and radiologic analysis.
619 Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes
of treatment and prognostic factors
Tristan D. Yan, BSc(Med), MBBS, PhD, Michael Boyer, MBBS, PhD, FRACP, Mo Mo Tin, MBBS,
Daniel Wong, MBBS, Catherine Kennedy, RM, RA, Jocelyn McLean, RN, MN, Paul G. Bannon,
MBBS, PhD, FRACS, and Brian C. McCaughan, MBBS, FRACS, Sydney, Australia
Extrapleural pneumonectomy-based multimodal therapy is associated with acceptable perioperative




625 Midterm results of endovascular treatment of complicated acute type B aortic
dissection
Ali Khoynezhad, MD, Carlos E. Donayre, MD, Bassam O. Omari, MD, George E. Kopchok, BS,
Irwin Walot, MD, and Rodney A. White, MD, Omaha, Neb, and Torrance, Calif
Twenty-eight patients underwent endovascular repair of complicated type B aortic dissection. Overall
survival rate was 82% and 78% at 1 and 5 years’ follow-up, respectively. The rate of treatment failure
according to Stanford criteria was 18% at 5 years. Thoracic aortic endografting can be performed with
acceptable morbidity and mortality in experienced hands.
632 Influence of prosthesis–patient mismatch on exercise-induced arrhythmias:
A further aspect after aortic valve replacement
Vito Antonio Mannacio, MD, Vincenzo De Amicis, MD, Luigi Di Tommaso, MD,
Francesco Iorio, MD, and Carlo Vosa, MD, Naples, Italy
This study evaluated occurrence of prosthesis–patient mismatch, long-term outcome, LV mass
regression, exercise tolerance, and arrhythmias in 157 patients who underwent AVR for pure AS
with a size 19- or 21-mm prosthesis and good LV function.
(continued on page 20A)














TX639 Prosthesis–patient mismatch is less frequent and more clinically indolent in
patients operated for aortic insufficiency
Joel Price, MD, Harry Lapierre, MD, Ladislaus Ressler, MD, Buu-Khanh Lam, MD, MPH,
Thierry G. Mesana, MD, PhD, and Marc Ruel, MD, MPH, Ottawa, Ontario, Canada
The incidence and significance of prosthesis–patient mismatch (PPM) differs in patients with aortic
insufficiency (AI) compared with those with aortic stenosis or mixed disease. In patients with lone AI,
PPM is seen less frequently and has no significant effect on survival and freedom from heart failure.
646 Cell therapy with autologous bone marrowmononuclear stem cells is associated
with superior cardiac recovery comparedwith use of nonmodifiedmesenchymal
stem cells in a canine model of chronic myocardial infarction
Myrielle Mathieu, DVM, Jozef Bartunek, MD, PhD, Bachar El Oumeiri, MD, Karim Touihri, MD,
Ielham Hadad, MS, Philippe Thoma, MD, Thierry Metens, MS, PhD,
Agnes Mendes da Costa, DVM, Maryam Mahmoudabady, MD, Dominique Egrise, MS, PhD,
Didier Blocklet, MD, Naı¨ma Mazouz, MS, PhD, Robert Naeije, MD, PhD,
Guy Heyndrickx, MD, PhD, and Kathleen McEntee, DVM, PhD, Brussels, Braine L’Alleud
and Aalst, Belgium; and TU Eindhoven, The Netherlands
We compared bone marrow mononuclear cell and mesenchymal stem cell therapy in a canine model
of chronic myocardial infarction. Mononuclear cells were superior to mesenchymal stem cells in
improvement of cardiac systolic function and reduction of infarct size and N-terminal B-type
natriuretic propeptide level. This was associated with a favorable angiogenic environment and
neovascularization.
654 Midterm clinical and echocardiographic results and predictors of mitral
regurgitation recurrence following restrictive annuloplasty for ischemic
cardiomyopathy
Francesco Onorati, MD, Antonino S. Rubino, MD, Domenico Marturano, MD, Eugenia Pasceri,
MD, Giuseppe Santarpino, MD, Stefania Zinzi, MD, Giuseppina Mascaro, MD, and Attilio Renzulli,
MD, PhD, FECTS, Catanzaro, Italy
Effects and predictors of recurrent ICMR following mitral restrictive annuloplasty (MRA)1CABG
were evaluated. MRA failure correlated with mortality, heart failure, absence of cardiac reverse
remodeling. Previous anterior1posterior infarcts, preoperative ventricular dilation, and coaptation
depth at discharge $ 0.5 cm predict recurrence. Prognosis of MRA is good, as long as a low
postoperative coaptation depth is achieved.
663 Surgical left ventricular remodeling leads to better long-term survival and
exercise tolerance than coronary artery bypass grafting alone in patients
with moderate ischemic cardiomyopathy
Omer Dzemali, MD, Petar Risteski, MD, Farhad Bakhtiary, MD, Eduard Singer,
Andreas Zierer, MD, Peter Kleine, MD, PhD, and Anton Moritz, MD, PhD,
Frankfurt am Main, Germany
Patients with coronary disease and impaired left ventricular function were treated with coronary
artery bypass grafting (group 1, n 5 165) or open left ventricular remodeling in addition to
revascularization (group 2, n5 120). Group 2 showed longer ventilation times and higher blood loss,
but lower operative mortality, improved long-term survival, and quality of life.
(continued on page 21A)

















TX669 Transit-time flow characteristics of in situ right gastroepiploic arterial grafts
in coronary artery bypass grafting
Yoshiyuki Takami, MD, Kazuyoshi Tajima, MD, Sachie Terazawa, MD, Noritaka Okada, MD,
Kei Fujii, MD, and Yoshimasa Sakai, MD, Nagoya, Japan
We classified intraoperative transit-time flow profiles of patent in situ gastroepiploic arterial grafts
into four types, closely associated with disease severity of target coronary artery. Patent in situ
gastroepiploic arterial grafts showed more regurgitant flow and lower differentiated index of early
diastolic flow than in situ internal thoracic arterial grafts.
674 A new vascular ring connector in surgery for aortic dissection
Jeng Wei, MD, MSD, Chung-Yi Chang, MD, Yi-Cheng Chuang, MD, Sung-How Sue, MD,
Kuo-Chen Lee, MD, and David Tung, MD, Taipei, Taiwan
We present the first clinical report of the successful use of a novel titanic vascular ring connector in
the surgical reconstruction of aortic dissection.
Perioperative
Management (PM)
678 Statins for prevention of atrial fibrillation after cardiac surgery: A systematic
literature review
Oliver J. Liakopoulos, MD, Yeong-Hoon Choi, MD, Elmar W. Kuhn, MD, Thorsten Wittwer, MD,
Michal Borys, MD, Navid Madershahian, MD, Gernot Wassmer, PhD, and Thorsten Wahlers, MD,
Cologne, Germany
The current meta-analysis of 13 studies (n 5 17,643 patients) provides evidence that statin
pretreatment may reduce the incidence of any (OR, 0.64; 95% CI, 0.48–0.87) or new-onset atrial
fibrillation (OR, 0.66; 95% CI, 0.48–0.89; P , .01) after cardiac surgery. Nevertheless, significant
heterogeneity among studies and publication bias underscore the need for future randomized
controlled trials.
687 Costs of excessive postoperative hemorrhage in cardiac surgery
Michael C. Christensen, MSc, MPA, DrPH, Stephan Krapf, MD, Angela Kempel, MSc, and
Christian von Heymann, MD, PhD, DEAA, Bagsværd, Denmark; and Augsburg, Freiburg, and
Berlin, Germany
Excessive postoperative hemorrhage in cardiac surgery is a serious clinical complication that places
substantial demands on hospital resources. In a retrospective analysis of data collected at the Heart
Center, Augsburg, Germany, we find incremental hospital costs of V6251 (95% CI, 4594 to 7909).
Excessive hemorrhage was also associated with a significant risk of postoperative complications and
death. Clinical interventions that can effectively prevent or address excessive postoperative
hemorrhage in cardiac surgery are likely to have substantial cost-effectiveness potential.
694 Thromboelastometry-guided administration of fibrinogen concentrate for the
treatment of excessive intraoperative bleeding in thoracoabdominal aortic
aneurysm surgery
Niels Rahe-Meyer, MD, MSc, PhD, Cristina Solomon, MD, Michael Winterhalter, MD,
Siegfried Piepenbrock, MD, Kenichi Tanaka, MD, MSc, PhD, Axel Haverich, MD, and Maximilian
Pichlmaier, MD, Atlanta, Ga, and Hannover, Germany
In this study of patients undergoing elective thoracoabdominal aortic aneurysm surgery, the efficacy
of intraoperative fibrinogen concentrate administration after cardiopulmonary bypass was assessed.
Administration of fibrinogen concentrate at doses guided by thromboelastometric data (ROTEM
FIBTEM) was associated with reduced transfusion of allogeneic blood products and lower 24-hour
drainage volume.
(continued on page 22A)














TX703 Hetastarch increases the risk of bleeding complications in patients after
off-pump coronary bypass surgery: A randomized clinical trial
Marketa Hecht-Dolnik, MD, Howard Barkan, DrPH, Ananse Taharka, MD, and John Loftus, MD,
Oakland and Berkeley, Calif
Our randomized clinical trial of patients undergoing off-pump coronary artery bypass grafting
found the intraoperative use of hetastarch for volume replacement to be associated with increases
in bleeding, transfusion requirements, and the likelihood of receiving a transfusion on postoperative
day 1.
712 Preventing heart injury during negative pressure wound therapy in cardiac
surgery: Assessment using real-time magnetic resonance imaging
Malin Malmsjo¨, MD, PhD, Rainer Petzina, MD, Martin Ugander, MD, PhD,
Henrik Engblom, MD, PhD, Christian Torbrand, MD, Arash Mokhtari, MD, PhD,
Roland Hetzer, MD, PhD, Ha˚kan Arheden, MD, PhD, and Richard Ingemansson, MD, PhD,
Lund, Sweden, and Berlin, Germany
MRI assessment in a porcine sternotomywoundmodel show altered position of the heart in relation to
the sternum during negative pressure wound therapy (NPWT). This may explain 2 potentially
hazardous events associated with NPWT, namely, risk for heart rupture and reduced cardiac output.
Inserting a rigid barrier over the heart may be a protective measure that is clinically practicable.
Evolving Technology/
Basic Science (ET/BS)
718 An expansible aortic ring for a physiological approach to conservative aortic
valve surgery
Emmanuel Lansac, MD, PhD, Isabelle Di Centa, MD, Franc¸ois Raoux, MD, Neil Bulman-Fleming,
Adrian Ranga, Aicha Abed, MSc, Maguette Ba, MD, Anthony Paolitto, Didier Letourneur, PhD, and
Anne Meddahi-Pelle´, MD, PhD, Paris, Suresnes, Boulogne–Billancourt, Le Plessis Robinson,
Villetaneuse, and Orle´ans, France; and Montre´al, Que´bec, Canada
An expansible aortic ring was designed to treat dystrophic aortic insufficiency. The device is
implanted externally to increase coaptation height by reducing the dilated aortic root diameters while
maintaining root dynamics. The properties of the device were tested in vitro and in vivo in an ovine
model.
725 Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis
and binds to components of vegetations
Hanna Mu¨ller, MD, Marcus Renner, PhD, Burkhard M. Helmke, MD, Caroline End, PhD,
Christel Weiss, PhD, Johannes Poeschl, MD, and Jan Mollenhauer, PhD, Heidelberg,
Frankfurt/Main, Mannheim, Germany; and Odense, Denmark
The glycoprotein DMBT1 is a scavenger receptor cysteine-rich protein with functions in epithelial
differentiation and suppression of infection via bacterial aggregation. We report that DMBT1 is up-
regulated in affected heart valves with bacterial endocarditis and is able to bind platelets, erythrocyte
membranes, and fibrin/fibrinogen.
733 Percutaneous reimplantation of a pulmonary valved stent in sheep: A potential
treatment for bioprosthetic valve degeneration
Yuan Bai, MD, Gang-Jun Zong, MD, Hai-Bing Jiang, MD, Wei-Ping Li, MD, Hong Wu, MD,
Xian-Xian Zhao, MD, and Yong-Wen Qin, MD, Shanghai and Jiangsu Province, China
To study the replacement of degenerated bioprosthetic valves with transcatheter reimplantation of
stent-mounted pulmonary valves, 6 sheep underwent percutaneous pulmonary valved stent
implantation. After 2 months of follow-up, reimplantation of stent-mounted pulmonary valves was
performed in these sheep. Echocardiography confirmed that the stents were in the desired position
during follow-up.
(continued on page 24A)
















738 Heart–lung transplantation in patients with pulmonary atresia and ventricular
septal defect
Katarzyna Januszewska, MD, PhD, Edward Malec, MD, PhD, Gerd Juchem, MD, PhD,
Ingo Kaczmarek, MD, PhD, Ralf Sodian, MD, PhD, Peter Uberfuhr, MD, PhD, and
Bruno Reichart, MD, PhD, Munich, Germany
Heart–lung transplantation for patients with pulmonary atresia and ventricular septal defect is
challenging and requires carefully planned and meticulously performed surgical intervention. This
management should be taken into consideration as a future option if the specific anatomy is
uncorrectable in early periods of life, and the palliative procedures should be avoided.
744 Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine
in rat heart transplantation
Yosuke Tanaka, MD, Tomomi Hasegawa, MD, PhD, Zhi Chen, MD, Yutaka Okita, MD, PhD, and
Kenji Okada, MD, PhD, Kobe, Japan
We evaluated the efficacy of the peroxisome proliferator–activated receptor g activator pioglitazone
in rat heart transplantation. Pioglitazone can reduce a dose of cyclosporine with sufficient
immunosuppressive effects. Pioglitazone treatment with low-dose cyclosporine protects both cardiac
allografts and recipient kidneys synergistically, leading to improvement of graft survival with
a minimal cyclosporine-induced nephrotoxicity.
752 Apyrase treatment prevents ischemia–reperfusion injury in rat lung isografts
Seiichiro Sugimoto, MD, PhD, Xue Lin, MD, Jiaming Lai, MD, Mikio Okazaki, MD, PhD,
Nitin A. Das, MD, Wenjun Li, MD, Alexander S. Krupnick, MD, Ridong Chen, PhD,
Soon Seog Jeong, PhD, G. A. Patterson, MD, Daniel Kreisel, MD, PhD, and
Andrew E. Gelman, PhD, St Louis, Mo
Administration of a soluble recombinant apyrase improves function and attenuates inflammation in
rat lung grafts following prolonged cold storage.
760 In vitro modeling of nonhypoxic cold ischemia–reperfusion simulating lung
transplantation
Monica Casiraghi, MD, Jason R. Tatreau, BS, John B. Abano, MD, John W. Blackwell, BS,
Larry Watson, MD, Keith Burridge, PhD, Scott H. Randell, PhD, and Thomas M. Egan, MD, MSc,
Chapel Hill, NC, and Milan, Italy
We describe a cell culture model of ischemia–reperfusion injury that depicts what lung tissue
experiences during transplantation. Consistant with changes observed in lung tissue in vivo,
endothelial cells exposed to simulated cold ischemia develop cytoskeletal alterations and monolayer
gap formation during ischemia and activation of inflammatory signaling cascades with simulated
warm reperfusion.
Brief Technique Reports 768 Open versus endovascular repair of traumatic aortic rupture: A systematic
review
Enoch Akowuah, MD, MRCS, FRCS (C-Th), Gianni Angelini, MD, MCh, FRCS, and
Alan J. Bryan, DM, FRCS (C-Th), Bristol, United Kingdom
770 The treatment of recurrent aortic prosthetic detachment with modified Bentall
procedure: Results of two cases
Chong Zhang, MD, Yiming Ni, MD, Liping Shi, MD, and Tao Jin, MD, Hangzhou, China
(continued on page 26A)














TX771 Successful emergency surgery for coexistent acute aortic syndrome and acute
carotid artery obstruction
Masahiko Ando, MD, Kazuhito Imanaka, MD, Hideaki Yamabi, MD, and Hiroshige Sato, MD,
Saitama, Japan
773 Video-assisted cardioscopy in the repair of persistent mitral paraprosthetic leak
Narain Moorjani, MD, FRCS, Jack Broadhurst, MB ChB, and Sunil Ohri, MD, FRCS, Southampton,
United Kingdom
775 Biologic anastomosis: The first case of biologic coronary bypass surgery
Masashi Komeda, MD, PhD, Akira Marui, MD, PhD, Keiichi Tambara, MD, PhD,
Masaya Yamamoto, PhD, Yoshiaki Saji, MD, Takeshi Nishina, MD, PhD, and
Yasuhiko Tabata, PhD, DMSc, DPharm, Kyoto and Aichi, Japan
777 Technical options for the treatment of anomalous origins of right or left
coronary arteries associated with aortopulmonary windows
Bertrand Le´obon, MD, Emmanuel Le Bret, MD, PhD, Re´gine Roussin, MD, Chokri Kortas, MD,
Mohammed Ly, MD, Anne Sigal-Cinqualbre, MD, Emre Belli, MD, and Alain Serraf, MD, PhD,
Le Plessis-Robinson, France
779 Total thoracic aorta reconstruction against graft infection in a patient with
chronic empyema developed after lung cancer surgery
Jun Yokote, MD, Akihiko Usui, MD, Hideki Oshima, MD, Noriyasu Usami, MD, Kohei Yokoi, MD,
and Yuichi Ueda, MD, Nagoya, Japan
781 Single-stage repair of aortopulmonary window with interrupted aortic arch
by transection of the aorta and direct reconstruction
Masahiro Yoshida, MD, Masahiro Yamaguchi, MD, PhD, Yoshihiro Oshima, MD, PhD,
Shigeteru Oka, MD, PhD, Tomonori Higuma, MD, and Yutaka Okita, MD, PhD,
Kobe and Akashi, Japan
Letters to the Editor 784 The left ventricle: To reconstruct or not—Lessons from the STICH trial
Teresa Mary Kieser, MD, FRCSC, FACS, Calgary, Alberta, Canada
784 Clarification of statements made regarding investigation into Amplatzer device
complication incidence and comparison with the Society of Thoracic Surgery
database
Daniel J. DiBardino, MD, Boston, Mass
785 Michael E. DeBakey
Shahbudin H. Rahimtoola, MB, FRCP, DSc (Hon), Los Angeles, Calif
785 Pulmonary arterial hypertension and congenital heart disease: Targeted
therapies and operability
Maurice Beghetti, MD, and Cecile Tissot, MD, Geneva, Switzerland
786 Reply to the Editor
Konrad Hoetzenecker, MD, Hendrik J. Ankersmit, MD, and Irene M. Lang, MD, Vienna, Austria
786 Quality of life in patients with prosthesis–patient mismatch
Stefano Salizzoni, MD, Pittsburgh, Pa
(continued on page 27A)

















TX787 Prosthesis–patient mismatch does not affect survival and quality of life in the
elderly having bileaflet prostheses implant
Mariano Vicchio, MD, PhD, Marisa De Feo, MD, PhD, and Maurizio Cotrufo, MD, Naples, Italy
788 Reply to the Editor
Marc R. Moon, MD, Saint Louis, Mo
789 Proximal brachiocephalic artery access for arterial cannulation: Value and
technical issues
Benjamin B. Peeler, MD, Charlottesville, Va
789 Reply to the Editor
Nathalie Roy, MD, Ivan M. Rebeyka, MD, Joseph Atallah, MD, and David B. Ross, MD, Edmonton,
Alberta, Canada
790 The link between previous percutaneous coronary intervention and coronary
artery bypass graft risk
Ravinay Bhindi, MBBS, PhD, FRACP, FESC and Oliver J. Omerod, DM, FRCP, Oxford,
United Kingom
790 Reply to the Editor
Parwis Massoudy, MD, Matthias Thielmann, MD, and Heinz Jakob, MD, Essen, Germany
790 A meta-analysis of controlled studies of preoperative statin therapy for
prevention of postoperative mortality in cardiac surgery
Hisato Takagi, MD, PhD, and Takuya Umemoto, MD, PhD, Shizuoka, Japan
792 Reply to the Editor
Minoru Tabata, MD, MPH, Tokyo, Japan
792 Graft patency in coronary artery bypass versus off-pump coronary artery
bypass
Hisato Takagi, MD, PhD, and Takuya Umemoto, MD, PhD, Shizuoka, Japan
793 Reply to the Editor
Barnaby C. Reeves, DPhil, and Gianni D. Angelini, MD, FETCS, Bristol, United Kingdom
Notices of Correction 794 Correction of article by Abdel-Rahman U, Risteski P, Tizi K, Kerscher S,
Behjati S, Zwicker K, Scholz M, Brandt U, Moritz A, entitled Hypoxic
reoxygenation during initial reperfusion attenuates cardiac dysfunction and
limits ischemia–reperfusion injury after cardioplegic arrest in a porcine model
(2009;137:978-82).
794 Correction of article by Patel HJ, Williams DM, Meerkov M, Dasika NL,
Upchurch GR Jr, Deeb GM, entitled Long-term results of percuntaneous
management of malperfusion in acute type B aortic dissection: Implications for
thoracic aortic endovascular repair (2009;138:300-8).
Meeting Proceedings 795 Highlights from the 58th Annual Scientific Sessions of the American College
of Cardiology, March 28 to 31, 2009, Orlando, Florida
Frederic S. Resnic, MD, MSc, FACC, and Akshay Desai, MD, MPH, FACC, Boston, Mass
798 Society of Cardiovascular Anesthesiologists 31st annual meeting highlights
Colleen Koch, MD, Cleveland, Ohio
(continued on page 28A)
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